Insight Molecular Diagnostics Inc. Foreign Currency Transaction Gain (Loss), before Tax
Insight Molecular Diagnostics Inc. (IMDX) reported Foreign Currency Transaction Gain (Loss), before Tax of -$16.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$16.00K.
- Insight Molecular Diagnostics Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-06-30 was -$150.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month |
|---|---|---|
| 2026-06-30 | -$16.00K 10-Q · filed 2026-08-10 | -$11.00K 10-Q · filed 2026-08-10 |
| 2025-06-30 | -$150.00K 10-Q · filed 2026-08-10 | -$187.00K 10-Q · filed 2026-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |